Scientists have developed a web-based tool to help communities design an optimal wildfire evacuation plan.
For years, research showed that print reading, whether for leisure or school, improved developing readers’ ability to comprehend text. However, the explosive use of digital reading devices, constant access to these devices, and new types of reading materials have introduced new reading habits. Now, a new comprehensive review of research on digital leisure reading habits finds a virtually nonexistent relationship between digital reading and improvement in reading comprehension among students.
The vast majority of older adults – 83% -- think health insurers should cover medications that can help people with obesity manage their weight, a new poll of people age 50 to 80 finds. Nearly as many -- 76% -- believe Medicare should cover these drugs, which it cannot currently do under law.
Did you know that the oceans hold more uranium than can be found on land? Seawater could become another source of nuclear fuel, and researchers in ACS Central Science report a way to capture it effectively.
Did you know that the oceans hold more uranium than can be found on land? Seawater could become another source of nuclear fuel, and researchers in ACS Central Science report a way to capture it effectively.
Physician-scientists and other researchers from Sylvester Comprehensive Cancer Center will make presentations at the American Society of Hematology’s 2023 annual meeting Dec. 9-12. This tip sheet highlights several of those presentations.
Physician-scientists and other researchers from Sylvester Comprehensive Cancer Center will make presentations at the American Society of Hematology’s 2023 annual meeting Dec. 9-12. This tip sheet highlights several of those presentations.
More than one-eighth of the randomized trials of cancer drugs seeking regulatory approval in China in recent years used inappropriate controls to test the effectiveness and safety of the drugs, according to a new study published December 12th in the open access journal PLOS Medicine by Professor Xiaodong Guan of Peking University, China, and colleagues.
The targeted therapy combination of ibrutinib and venetoclax significantly improved progression-free survival (PFS) and achieved an overall remission rate in 82% of patients with relapsed/refractory mantle cell lymphoma (MCL), according to researchers at The University of Texas MD Anderson Cancer Center. Results from the Phase III SYMPATICO trial were presented at the 2023 American Society of Hematology (ASH) Annual Meeting.
In a study of more than 9,000 pregnant people from across the U.S., researchers at University of Utah Health found that cannabis exposure during pregnancy is associated with a composite measure of unhealthy pregnancy outcomes, especially low birth weight, and that higher exposure is associated with higher risks.
In a study of more than 9,000 pregnant people from across the U.S., researchers at University of Utah Health found that cannabis exposure during pregnancy is associated with a composite measure of unhealthy pregnancy outcomes, especially low birth weight, and that higher exposure is associated with higher risks.
The National Academy of Inventors (NAI) has elected two Ohio State University College of Medicine professors to its 2023 class of Fellows. Krystof Bankiewicz, MD, PhD in the Department of Neurological Surgery, and Michael Tweedle, PhD, professor emeritus in the Department of Radiology, are among the 162 academic inventors named NAI Fellows this year.
The National Academy of Inventors (NAI) has elected two Ohio State University College of Medicine professors to its 2023 class of Fellows. Krystof Bankiewicz, MD, PhD in the Department of Neurological Surgery, and Michael Tweedle, PhD, professor emeritus in the Department of Radiology, are among the 162 academic inventors named NAI Fellows this year.
Alcohol use on certain special occasions may contribute to harsher parenting by mothers, according to an innovative study.
Alcohol use on certain special occasions may contribute to harsher parenting by mothers, according to an innovative study.
Researchers conducting a Phase 2 clinical trial at Sylvester Comprehensive Cancer Center say a new combination of antibody therapies produced a ‘surprisingly high’ response rate in patients with high-risk follicular lymphoma, a type of non-Hodgkin lymphoma.
CAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even for patients regarded as high risk due to comorbidities. That’s the conclusion of a five-year analysis of results from the U.S. Lymphoma CAR-T Cell Consortium.
CAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even for patients regarded as high risk due to comorbidities. That’s the conclusion of a five-year analysis of results from the U.S. Lymphoma CAR-T Cell Consortium.
Non-Hispanic Black patients with acute myeloid leukemia (AML) are living longer, now that new therapies are available, according to a study presented by researchers from the University of Pennsylvania Perelman School of Medicine and Penn Medicine’s Abramson Cancer Center at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition (Abstract 955).
In a study led by researchers at Sylvester Comprehensive Cancer Center, patients recently diagnosed with a common and aggressive form of acute myeloid leukemia reported having improved quality of life when a newly approved drug was part of the treatment plan.
In a study led by researchers at Sylvester Comprehensive Cancer Center, patients recently diagnosed with a common and aggressive form of acute myeloid leukemia reported having improved quality of life when a newly approved drug was part of the treatment plan.
UC San Diego Health has successfully completed purchase of Alvarado Hospital Medical Center — will be renamed UC San Diego Health East Campus Medical Center.
As presented at the Society for Risk Analysis 2023 Annual conference, Patrycja Sleboda from Baruch College – CUNY and her colleagues from the University of Southern California conducted a national food choice experiment to determine how people respond to labels such as “vegan” and “plant-based” compared to “healthy,” “sustainable,” or “healthy and sustainable.”
New research results in JNCCN are encouraging regarding the benefit of immunotherapy for treating lung cancer across racial and ethnic groups, but also reinforce need to include more Black and Hispanic people in cancer clinical trials and highlight the importance of equitable treatment delivery for closing disparities in outcomes.
New research conducted by investigators at Sylvester Comprehensive Cancer Center and collaborating cancer centers indicates that a new type of targeted therapy may offer new treatment options for patients living with advanced myelofibrosis, a bone marrow disorder. Study results will be shared at ASH 2023 in San Diego, Dec. 9-12.
Physician-investigators compared a chatbot’s probabilistic reasoning to that of human clinicians. The findings, published in JAMA Network Open, suggest that artificial intelligence could serve as useful clinical decision support tools for physicians.
Physician-investigators compared a chatbot’s probabilistic reasoning to that of human clinicians. The findings, published in JAMA Network Open, suggest that artificial intelligence could serve as useful clinical decision support tools for physicians.
Lawrence Livermore National Laboratory (LLNL) researchers, along with scientists from more than a dozen institutions, have completed a first-of-its-kind high-resolution assessment of carbon dioxide (CO2) removal (CDR) in the United States.
Lawrence Livermore National Laboratory (LLNL) researchers, along with scientists from more than a dozen institutions, have completed a first-of-its-kind high-resolution assessment of carbon dioxide (CO2) removal (CDR) in the United States.
Investigators from the C.S. Mott Center for Human Growth and Development at the Wayne State University School of Medicine reported today in a publication in Cancer Immunology Research the characterization of a novel therapeutic approach capable of restoring immune surveillance and providing long-term protection against ovarian cancer tumors.
Investigators from the C.S. Mott Center for Human Growth and Development at the Wayne State University School of Medicine reported today in a publication in Cancer Immunology Research the characterization of a novel therapeutic approach capable of restoring immune surveillance and providing long-term protection against ovarian cancer tumors.
Learning that their peers’ alcohol use is declining over time may help reduce young adults’ drinking, according to the first study that tested this approach among community-based participants (versus college students).
It may feel unforgivably rude to reject an invitation – even one to an event you would much prefer not to attend – but people often overestimate the social consequences of saying no, according to research published by the American Psychological Association.
A study led by researchers at Sylvester Comprehensive Cancer Center suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into remission before the cell therapy begins. Downloadable video is available.
A study led by researchers at Sylvester Comprehensive Cancer Center suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into remission before the cell therapy begins. Downloadable video is available.
The treatment landscape for acute myeloid leukemia (AML) is evolving rapidly, as research discoveries at Sylvester Comprehensive Cancer Center and other academic cancer centers advance new, more effective therapies for this aggressive blood cancer.
The treatment landscape for acute myeloid leukemia (AML) is evolving rapidly, as research discoveries at Sylvester Comprehensive Cancer Center and other academic cancer centers advance new, more effective therapies for this aggressive blood cancer.
Combining the JAK inhibitor ruxolitinib with the BCL-xL inhibitor navitoclax was twice as effective in reducing enlarged spleens – a major indicator of clinical improvement – compared with standard-of-care ruxolitinib monotherapy for adult patients with intermediate or high-risk myelofibrosis, a rare bone marrow cancer, according to results of the Phase III TRANSFORM-1 trial reported by researchers from The University of Texas MD Anderson Cancer Center.
The targeted therapy bezuclastinib was safe and rapidly reduced markers of disease burden while also improving symptoms for patients with a rare blood disorder called nonadvanced system mastocytosis.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right